Uniplan Investment Counsel, Inc. Eyenovia, Inc. Transaction History

Uniplan Investment Counsel, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.61 - $5.1 $1.54 Million - $3.02 Million	-591,942 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.6 - $3.81 $39,150 - $57,370	-15,058 Reduced 2.48%	591,942 $1.68 Million
Q1 2020 May 15, 2020	BUY	$1.77 - $4.92 $150,949 - $419,587	85,282 Added 16.35%	607,000 $1.4 Million
Q4 2019 Feb 14, 2020	BUY	$2.67 - $4.48 $11,184 - $18,766	4,189 Added 0.81%	521,718 $2.34 Million
Q3 2019 Nov 14, 2019	SELL	$2.55 - $4.91 $69,785 - $134,371	-27,367 Reduced 5.02%	517,529 $1.91 Million
Q2 2019 Aug 14, 2019	BUY	$4.08 - $6.87 $407,575 - $686,285	99,896 Added 22.45%	544,896 $2.34 Million
Q1 2019 May 15, 2019	BUY	$2.63 - $6.3 $316,294 - $757,663	120,264 Added 37.03%	445,000 $2.67 Million
Q4 2018 Feb 14, 2019	SELL	$2.6 - $4.24 $158,308 - $258,165	-60,888 Reduced 15.79%	324,736 $925,000
Q3 2018 Nov 13, 2018	BUY	$4.02 - $7.22 $163,308 - $293,305	40,624 Added 11.78%	385,624 $1.55 Million
Q2 2018 Aug 14, 2018	SELL	$6.25 - $9.49 $62,500 - $94,900	-10,000 Reduced 2.82%	345,000 $2.17 Million
Q1 2018 May 14, 2018	BUY	$8.11 - $9.95 $2.88 Million - $3.53 Million	355,000 New	355,000 $3.25 Million

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $2.74M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.